BioTheryX Revenue and Competitors
Estimated Revenue & Valuation
- BioTheryX's estimated annual revenue is currently $3.3M per year.
- BioTheryX's estimated revenue per employee is $81,600
Employee Data
- BioTheryX has 41 Employees.
- BioTheryX grew their employee count by -24% last year.
BioTheryX's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Officer | Reveal Email/Phone |
2 | Executive Assistant/Officer Manager | Reveal Email/Phone |
3 | Senior Director, Finance & Accounting/Controller | Reveal Email/Phone |
4 | Director, Pharmacology | Reveal Email/Phone |
5 | Director, Business Development and Strategy | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Senior Director Medicinal Chemistry | Reveal Email/Phone |
8 | Executive Director, CMC | Reveal Email/Phone |
9 | Accounting Manager | Reveal Email/Phone |
10 | R&D Drug Discovery Biologist | Reveal Email/Phone |
BioTheryX Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24M | 214 | 10% | N/A | N/A |
#2 | $4.8M | 52 | -4% | N/A | N/A |
#3 | $2.9M | 36 | 9% | N/A | N/A |
#4 | $22.4M | 200 | 5% | N/A | N/A |
#5 | $1.7M | 24 | 9% | N/A | N/A |
#6 | $10.1M | 99 | -1% | N/A | N/A |
#7 | $5.8M | 63 | 9% | N/A | N/A |
#8 | $3.2M | 39 | N/A | N/A | N/A |
#9 | $5.8M | 63 | -3% | N/A | N/A |
#10 | $0.8M | 13 | N/A | N/A | N/A |
What Is BioTheryX?
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to develop treatments intended to extend and improve the quality-of-life of patients with life-threatening diseases. Our principal technology platform centers on targeted protein degradation, as well as PHM® ‘molecular glues', that enable the design of small molecules to regulate protein equilibrium. This technology is designed to utilize the body's own protein disposal system to selectively degrade and remove disease-causing proteins. It has potential applicability to a broad range of diseases, including targets that have to date been considered ‘undruggable'.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$3.3M
Revenue (est)
-24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioTheryX News
Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 41 | -18% | N/A |
#2 | $4.8M | 41 | 8% | N/A |
#3 | $7.5M | 41 | -13% | $269.2M |
#4 | $3.2M | 41 | -35% | $39.4M |
#5 | $8.9M | 41 | 3% | N/A |